Potelizio Intravenous infusion 20mg, manufactured by Kyowa Kirin, contains Mogamulizumab (genetical recombination). With YJ code 4291422A1021 and standard 20mg 5mL bottle, it is a monoclonal antibody used to treat certain types of adult T-cell leukemia/lymphoma.
Potelizio point Intravenous infusion 20mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).